DAFTAR PUSTAKA
Arunkumar, N., Deecaraman, M., Rani, C., Mohanraj, K. P., Kumar, K.V.,
2009. Preparation and Solid State Characterization of
Atorvastatin Nanosuspensions for Enhanced Solubility and
Dissolution. International Journal of PharmTech Research,
vol. 1 no. 4 Oct-Dec, p. 1725-1730.
Bergische Universität Wuppertal, 2007. Cyclodextrins,
http://www.chemiedidaktik.uni-wuppertal.de/, diakses pada
7/3/2014
Chandrakant, D. S., Danki, L. S., Sayeed, A., Kinagi, M. B., 2011.
Preparation and Evaluation of Inclusion Complexes of Water
Insoluble Drug. International Journal of Research in
Pharmaceutical Biomedical Science, vol. 2 (4) Oct-Dec, p.
1599-1616.
Challa, R., Ahuja, A., Ali, J., Khar, R. K., 2005. Cyclodextrins in Drug
Delivery: An Updated Review, AAPS PharmSciTech, 6 (2)
Article 43
Del Valle, E. M. M., 2003. Cyclodextrins and Their Uses: A Review.
Elsevier (Process Biochemistry)
Departemen Kesehatan RI, 1995. Farmakope Indonesia, Edisi IV. Jakarta:
Departemen Kesehatan, p. 979-981, 989-992, 1064-1065.
El-Assal, A. M., 2004. Mechanical Properties of Polymethyl MethacrylateKetoprofen Mixture in Stent and Splint Preparation. JKAU:
Eng. Sci., vol. 15 no. 2, p. 33-43.
Hui, X. L., Zhen, H.Z., Hui, J., Waddad, A. Y., Jian, P.Z., 2012.
Preparation, Physicochemical Characteristics and
Bioavailability Studies of An Atorvastatin Hydroxypropyl-βCyclodextrin Complex. Pharmazie, vol. 67, p. 46-53.
Isadiartuti, D., Suwaldi, 2005. Pembentukan Kompleks Inklusi Fenobarbital
dengan Hidroksipropil-β-Siklodekstrin. Majalah Farmasi
Indonesia, 16 (1), 28 – 37.
Katzung, B. G., 2006. Basic and Clinical Pharmacology, 10th Edition. San
Francisco: Mc Graw Hill Lange, p. 1069.
Kohata S., Jyodi K., Ohyoshi, A., 1993. Thermal Decomposition of
Cyclodextrins (α-, β-, γ-, and modified -CyD) and of Metal -(-
58
59
CyD) Complex in The Solid Phase. Thermochim Acta,
217:187-98.
Loftsson, T., Jarho, P., Masson, M., Jarvinen, T., 2005. Cyclodextrins in
Drug Delivery. Expert Opinion Drug Delivery, vol. 2, p. 335351.
Loftsson, T., Masson, M., Magnusdottir, A., 2002. Cyclodextrins. J. Incl.
Phenom. Macroc.Chem., vol. 44, p. 213-218.
Lu, W. L., Zhang, Q., Zheng, L., Wang, H., Li, R. Y., Zhang, L. F., Shen,
W. B., Tu, X. D., 2004. Antipyretic, Analgesic and Antiinflammatory Activities of Ketoprofen β-Cyclodextrin
Inclusion Complex in Animals. Biol. Pharm. Bull., vol. 27
(10), p.1515-1520.
Martin, A. N., 2009. Martin’s Physical Pharmacy and Pharmaceutical
Sciences, Physical Chemical and Biopharmaceutical Principles
in the Pharmaceutical Sciences, Sixth Edition. Baltimore,
Philadelhia: Lippincot Williams & Wilkins, p. 197-222.
Meislich, H., Nechamkin, H., Sharefkin, J., & Hademenos, G. (2010).
Schaum's Outlines Organic Chemistry, Fourth Edition. USA:
The McGraw-Hill Companies, Inc.
Morrison, R. T., & Boyd, R. N. (1973). Organic Chemistry,4th Edition.
Allya and Bacon, Inc.
Mulja, M., Suharman,1995. Analisis Instrumental. Surabaya: Airlangga
University Press.
O’Neil, M. J., Smith, A., Heckelman, P. E., 2001. The Merck Index, An
Encyclopedia Of Chemicals, Drugs, And Biologicals,
Thirteenth Edition. New Jersey: Merck & Co., Inc.
Patil, J. S., Kadam, D.V., Marapur, S. C., Kamalapur, M. V., 2010.
Inclusion Complex System; A Novel Technique to Improve
The Solubility and Bioavailability of Poorly Soluble Drugs: A
Review. International Journal of Pharmaceutical Sciences
Review and Research, p.29-34.
Pitha, J., Milecki, J., Fales, H., Panell, L., Vekama, K., 1985.
Hydroxypropyl-β-Cyclodextrin: Preparation and
Characterization; Effects on Solubility of Drugs. International
Journal of Pharmaceutics, vol 29, p. 73-82.
60
Rowe, R. C., Sheskey, P. J., Quinn, M. E., 2009. Handbook of
Pharmaceutical Excipients, Sixth Edition. Great Britain: RPS
Publishing, p. 210-214, 315-317.
Shohin, I. E., Kulinich, J. I., Ramenskaya, G. V., Vasilenko, G. F., 2011.
Evaluation of In Vitro Equivalence for Drugs Containing BCS
Class II Compound Ketoprofen. Dissolution Technologies, 1801-08.indd, p. 26-29.
Singh, R., Bharti, N., Madan, J., Hiremath, S. N., 2010. Characterization of
Cyclodextrin Inclusion Complex – A Review. Journal of
Pharmaceutical Science and Technology, Vol. 2 (3), p.171183.
Tayade, P. T., Vavia, P. R., 2006. Inclusion Complexes of Ketoprofen with
β-Cyclodextrins: Oral Pharmacokinetics of Ketoprofen in
Human. Indian Journal of Pharmaceutical Sciences, volume
68, issue 2, page 164-170.
Vikesh, S., Rajashree, M., Ashok, A., Manvi, F. V., 2009. Influence of βCyclodextrin Complexation on Ketoprofen Release from
Matrix Formulation. International Journal of Pharmaceutical
Sciences and Drug Research, vol. 1 (3), p. 195-202.